Merck obesity drug shows weight loss in study (Reuters)
Reuters - Merck & Co said on Monday that
patients on its experimental obesity drug lost more than twice
as much weight as those on a placebo in a late-stage clinical
study.
Oryginal: Reuters
Posted: March 31st, 2008 under NEWS.
Comments: none
Related articles
- Antipsychotics Dangerous for Elderly With Dementia (HealthDay) (May 27th, 2008)
- Health Tip: Get Your Child Back to Bed (HealthDay) (May 27th, 2008)
- Gum Disease Might Boost Cancer Risk (HealthDay) (May 27th, 2008)
- Researchers studying better insect repellants (AP) (May 27th, 2008)
- ADHD can cost adults 20 or more workdays a year (AP) (May 27th, 2008)